All In Biotech

Free tool

FAERS Monitor: Technetium Tc 99m Albumin Aggregated Kit

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming BLA 017881 or its brand name (Technetium Tc 99m Albumin Aggregated Kit, Technetium Tc-99m Albumin Aggregated Kit). Reports on generic versions are filed under their own applications.

Reports

30

Serious

5

17% of reports

Hospitalization

1

Death reported

1

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • drug ineffective17
  • off label use3
  • product preparation issue3
  • pruritus3
  • radioisotope uptake increased3
  • accidental underdose2
  • dyspnoea2
  • product distribution issue2
  • product preparation error2
  • rash2
  • urticaria2
  • anaphylactic reaction1
  • anaphylactoid reaction1
  • cardiac arrest1
  • cough1

Reports by year received

View as table
YearReports
20141
20161
20171
20182
20192
20203
20214
20225
20233
20244
20254

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,054,129 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
radioisotope uptake increasedSignal351351.516816.799,684
product preparation issueSignal3320.8109.6663
anaphylactoid reaction1170.424.842
product distribution issue2151.239.6167
accidental underdose297.425.5107
product preparation error268.317.974
anaphylactic reaction112.71.82
drug ineffectiveSignal179.06.6121
cardiac arrest18.51.21
urticaria28.42.27
pruritusSignal35.51.97
rash23.20.81
cough12.50.40
dyspnoea22.50.61
off label use32.40.81

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.